Janus Henderson has cut valuation of its stake in e-pharmacy unicorn PharmEasy for the second time, The Economic Times reported citing US SEC filings. After valuing the startup at $2.8 billion as of December 31, the asset management company has now cut PharmEasy's valuation to $2.7 billion. Another PharmEasy investor Neuberger Berman had cut valuation by 21% to $4.4 billion.